Porteous 2013.

Trial name or title	Help for Hayfever
Methods	Design: pilot cluster‐RT Groups: intervention group (hay fever management); control group (usual care)
Participants	Pharmacies:12 Pharmacy workers: at least one pharmacist and pharmacy assistant per pharmacy ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ Pharmacy users: 144 patients with allergic rhinitis Setting: unclear Country: Scotland
Interventions	Pharmacy worker‐directed intervention: 3‐hour training workshop in self‐management theory, the use of goal‐setting as a behaviour‐change technique ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ Pharmacy user‐directed intervention: setting and achieving goals that aim to avoid/minimise triggers for, and eliminate/minimise symptoms of allergic rhinitis, including problem solving Delivered by: pharmacy workers Type: behaviour change Mode of delivery: face‐to‐face Duration: unclear Pharmacy user control: usual care
Outcomes	Pharmacy worker: uptake ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ Pharmacy user: Clinical: symptom severity Psychological health: not assessed Behavioural: medication adherence Quality of life: mini‐rhinoconjunctivitis quality of life questionnaire, EQ‐5D Costs: pharmacy and health service costs, QALYs
Starting date	April 2012
Contact information	t.porteous@abdn.ac.uk
Notes	Funded by the Chief Scientist Office of the Scottish Government.